Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Estimates with and without ductal carcinoma in situ (DCIS)

From: Breast cancer tumor growth estimated through mammography screening data

Data used Time taken (years) to grow from 10 mm to 20 mm Volume doubling time (days) at 15 mm Screening test sensitivity Indicators of potential screening efficacy
  Mean Standard deviation 25th percentile 50th percentile 75th percentile 5 mm 10 mm Mean sojourn time (years) Proportion of tumors visible on screening
With ductal carcinoma in situ 1.7 2.2 41 99 234 26 91 2.9 0.95
Without ductal carcinoma in situ 1.5 1.9 44 96 209 23 91 2.5 0.95
  1. All other estimates in the present article are given including ductal carcinoma in situ.